O
CME icon

OppenheimerFunds’s CME Group CME Stock Holding History

OppenheimerFunds’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$52.7M Sell
319,967
-614,828
-66% -$109M 0.07% 302
2018
Q4 		$176M Sell
934,795
-815,363
-47% -$151M 0.25% 104
2018
Q3 		$298M Sell
1,750,158
-143,313
-8% -$24.1M 0.35% 73
2018
Q2 		$310M Sell
1,893,471
-78,444
-4% -$12.8M 0.37% 65
2018
Q1 		$319M Sell
1,971,915
-258,218
-12% -$41.1M 0.4% 56
2017
Q4 		$326M Sell
2,230,133
-171,999
-7% -$24.5M 0.39% 58
2017
Q3 		$326M Sell
2,402,132
-76,845
-3% -$9.71M 0.4% 64
2017
Q2 		$310M Sell
2,478,977
-371,496
-13% -$44.4M 0.38% 69
2017
Q1 		$339M Sell
2,850,473
-1,781,128
-38% -$214M 0.41% 65
2016
Q4 		$534M Buy
4,631,601
+708,845
+18% +$78.9M 0.68% 18
2016
Q3 		$410M Sell
3,922,756
-948,193
-19% -$99M 0.51% 41
2016
Q2 		$474M Sell
4,870,949
-23,169
-0.5% -$2.19M 0.62% 30
2016
Q1 		$470M Buy
4,894,118
+177,308
+4% +$16.1M 0.62% 31
2015
Q4 		$427M Sell
4,716,810
-367,334
-7% -$34.6M 0.54% 41
2015
Q3 		$472M Buy
5,084,144
+746,946
+17% +$71M 0.64% 26
2015
Q2 		$404M Buy
4,337,198
+366,586
+9% +$34.2M 0.46% 49
2015
Q1 		$376M Sell
3,970,612
-364,050
-8% -$33.7M 0.42% 57
2014
Q4 		$384M Sell
4,334,662
-624,920
-13% -$53M 0.43% 55
2014
Q3 		$397M Sell
4,959,582
-95,176
-2% -$7.17M 0.44% 56
2014
Q2 		$359M Sell
5,054,758
-198,169
-4% -$13.9M 0.4% 64
2014
Q1 		$389M Buy
5,252,927
+3,475,992
+196% +$262M 0.46% 48
2013
Q4 		$139M Sell
1,776,935
-1,654,901
-48% -$130M 0.17% 161
2013
Q3 		$254M Buy
3,431,836
+1,232,488
+56% +$90.8M 0.17% 158
2013
Q2 		$167M Buy
+2,199,348
New +$144M 0.24% 109

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OppenheimerFunds's CME Position: Q1 2019 in Review

OppenheimerFunds reduced its CME Group (CME) stake by 66% in Q1 2019, selling an estimated $109M and leaving 319,967 shares worth $52.7M. The position accounts for 0.07% of the portfolio, ranked #302.

OppenheimerFunds first reported a position in CME in Q2 2013 and has held it in 24 quarters since. The position peaked at $534M in Q4 2016. 1,003 funds tracked by Wall St. Rank hold CME as of Q1 2019.

  • OppenheimerFunds held 319,967 shares of CME Group worth $52.7M as of Q1 2019.
  • OppenheimerFunds sold 614,828 CME Group shares in Q1 2019, an estimated $109M.
  • CME Group made up 0.07% of OppenheimerFunds's portfolio in Q1 2019, its #302 holding.
  • OppenheimerFunds first reported a position in CME Group in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's CME Group position peaked at $534M in Q4 2016.
  • 1,003 funds tracked by Wall St. Rank held CME Group as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.